Trial Profile
A phase I trial assessing the pharmacokinetics of buprenorphine/naloxone for the treatment of opioid dependence.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2011
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 08 Sep 2011 New trial record